Physician profile
Akhil Narang
NPI 1417260548
$363,170.37
in general payments reported to CMS, 2019-2025
16 companies · $118K in 2025
The $118K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,304 · 2020: $1,447 · 2021: $462 · 2022: $6,961 · 2023: $125K · 2024: $107K · 2025: $118K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $199K · Consulting Fee: $105K · Travel and Lodging: $36K · Food and Beverage: $10K · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $198,730.00 |
| Consulting Fee | $105,007.50 |
| Travel and Lodging | $36,057.84 |
| Food and Beverage | $10,183.40 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $224,253.83 | 2022-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $98,371.06 | 2019-2025 | Pascal, Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ge Healthcare | $21,562.93 | 2025 | |
| Abbott Laboratories | $9,446.51 | 2019-2025 | Mitraclip, Triclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Lantheus Medical Imaging, INC. | $6,508.87 | 2022-2023 | Definity |
| Philips North America LLC | $2,149.99 | 2019-2025 | Peripheral Vascular Undivided, Igt Devices Undivided, (Aj8) Clinical Partnerships Na & Gcpc |
| Heartflow, INC. | $343.49 | 2022-2025 | |
| Bracco Diagnostics INC. | $123.82 | 2022 | |
| Boston Scientific Corporation | $119.85 | 2022 | |
| Pfizer INC. | $94.55 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.23 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $36.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.17 | 2024 | |
| Novo Nordisk INC | $25.18 | 2021 | |
| Amgen INC. | $17.26 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akhil Narang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.